{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:49:35Z","timestamp":1791229775608,"version":"4.1.0"},"reference-count":12,"publisher":"Elsevier BV","issue":"21","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.vaccine.2022.04.027","type":"journal-article","created":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T17:13:28Z","timestamp":1649870008000},"page":"2899-2903","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Safety and immunogenicity of HepB-CpG in women with documented pregnancies post-vaccination: A retrospective chart review"],"prefix":"10.1016","volume":"40","author":[{"given":"Tatyana","family":"Kushner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Janssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2022.04.027_b0005","unstructured":"Adult Immunization Schedule Recommendations for Ages 19 Years or Older, United States, 2022. https:\/\/www.cdc.gov\/vaccines\/schedules\/hcp\/imz\/adult.html; 2022. [Accessed 17 February 2022]."},{"key":"10.1016\/j.vaccine.2022.04.027_b0010","unstructured":"Heplisav-B. Package Insert. Dynavax Technologies Corporation; 2020."},{"key":"10.1016\/j.vaccine.2022.04.027_b0015","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.reprotox.2017.09.006","article-title":"Signal management in pharmacovigilance and human risk assessment of CpG 7909, integrating embryo-fetal and post-natal developmental toxicity studies in rats and rabbits","volume":"75","author":"Delannois","year":"2018","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.vaccine.2022.04.027_b0020","unstructured":"Jhaveri R, Walker R, Janssen R. Immunogenicity and safety of a 2-dose Hepatitis B Vaccine, HEPLISAV-B in Adolescents. Pediatric Academic Societies (PAS) 2021 Virtual Meeting, April 30\u2013May 4; 2021."},{"issue":"2","key":"10.1016\/j.vaccine.2022.04.027_b0025","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.vaccine.2011.10.086","article-title":"Comparison of immune responses and protective efficacy of intranasal prime-boost immunization regimens using adenovirus-based and CpG\/HH2 adjuvanted-subunit vaccines against genital Chlamydia muridarum infection","volume":"30","author":"Brown","year":"2012","journal-title":"Vaccine"},{"issue":"46","key":"10.1016\/j.vaccine.2022.04.027_b0030","doi-asserted-by":"crossref","first-page":"5300","DOI":"10.1016\/j.vaccine.2013.05.068","article-title":"Immunogenicity and safety of an investigational hepatitis B vaccine with a Toll-like receptor 9 agonist adjuvant (HBsAg-1018) compared to a licensed hepatitis B vaccine in healthy adults 40\u201370 years of age","volume":"31","author":"Heyward","year":"2013","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2022.04.027_b0035","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.vaccine.2017.12.038","article-title":"Immunogenicity of a two-dose investigational hepatitis B vaccine, HBsAg-1018, using a toll-like receptor 9 agonist adjuvant compared with a licensed hepatitis B vaccine in adults","volume":"36","author":"Jackson","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.04.027_b0040","unstructured":"ACOG Clinical Guidance: Maternal immunization. <https:\/\/www.acog.org\/clinical\/clinical-guidance\/committee-opinion\/articles\/2018\/06\/maternal-immunization> [accessed on 8\/2021]."},{"issue":"5","key":"10.1016\/j.vaccine.2022.04.027_b0045","doi-asserted-by":"crossref","first-page":"158","DOI":"10.15585\/mmwr.mm6705e3","article-title":"Advisory committee on immunization practices recommended immunization schedule for adults aged 19 years or older - United States, 2018","volume":"67","author":"Kim","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2022.04.027_b0050","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1432-2277.2009.00908.x","article-title":"Successful management of a same-day emergency delivery and liver transplant in a 27 weeks pregnant woman with fulminant hepatic failure","volume":"23","author":"Toti","year":"2010","journal-title":"Transpl Int"},{"issue":"9","key":"10.1016\/j.vaccine.2022.04.027_b0055","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1111\/jvh.13565","article-title":"The effects of hepatitis B virus infection on natural and IVF pregnancy: a meta-analysis study","volume":"28","author":"Farsimadan","year":"2021","journal-title":"J Viral Hepat"},{"issue":"40","key":"10.1016\/j.vaccine.2022.04.027_b0060","doi-asserted-by":"crossref","first-page":"6215","DOI":"10.1016\/j.vaccine.2020.07.041","article-title":"Safety evaluation of adverse events following vaccination with Havrix, Engerix-B or Twinrix during pregnancy","volume":"38","author":"Celzo","year":"2020","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22004431?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22004431?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:11:22Z","timestamp":1759403482000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X22004431"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":12,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S0264410X22004431"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.04.027","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and immunogenicity of HepB-CpG in women with documented pregnancies post-vaccination: A retrospective chart review","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.04.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}